IN2013MU02055A - - Google Patents

Info

Publication number
IN2013MU02055A
IN2013MU02055A IN2055MU2013A IN2013MU02055A IN 2013MU02055 A IN2013MU02055 A IN 2013MU02055A IN 2055MU2013 A IN2055MU2013 A IN 2055MU2013A IN 2013MU02055 A IN2013MU02055 A IN 2013MU02055A
Authority
IN
India
Prior art keywords
amorphous linagliptin
preparation
provides
improved process
linagliptin
Prior art date
Application number
Other languages
English (en)
Inventor
Shriprakash Dhar Dwivedi
Kumar Kamlesh Singh
Jitendra Maganbhai Gajera
Dipak Ambalal Patel
Srinivasu Ramani
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN2055MU2013 priority Critical patent/IN2013MU02055A/en
Publication of IN2013MU02055A publication Critical patent/IN2013MU02055A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN2055MU2013 2013-06-18 2013-06-18 IN2013MU02055A (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN2055MU2013 IN2013MU02055A (ko) 2013-06-18 2013-06-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN2055MU2013 IN2013MU02055A (ko) 2013-06-18 2013-06-18

Publications (1)

Publication Number Publication Date
IN2013MU02055A true IN2013MU02055A (ko) 2015-07-03

Family

ID=54396351

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2055MU2013 IN2013MU02055A (ko) 2013-06-18 2013-06-18

Country Status (1)

Country Link
IN (1) IN2013MU02055A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019064214A1 (en) * 2017-09-27 2019-04-04 Biocon Limited INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019064214A1 (en) * 2017-09-27 2019-04-04 Biocon Limited INTERMEDIATE OF CRYSTALLINE LINAGLIPTIN AND PROCESS FOR THE PREPARATION OF LINAGLIPTIN
US11040974B2 (en) 2017-09-27 2021-06-22 Biocon Limited Crystalline linagliptin intermediate and process for preparation of linagliptin

Similar Documents

Publication Publication Date Title
TN2015000278A1 (en) Autotaxin inhibitors
PH12015501648B1 (en) 2-aminopyrimidine derivatives for the treatment of viral infections
PH12016501122A1 (en) Delayed release compositions of linaclotide
MY169159A (en) Piperidino-pyrimidine derivatives for the treatment of viral infections
UA118341C2 (uk) Гетероциклічні заміщені похідні 2-амінохіназоліну для лікування вірусних інфекцій
SG10201908839QA (en) 2,4-dihydroxy-nicotinamides as apj agonists
PH12014501991B1 (en) Phenicol antibacterials
PH12015500724A1 (en) 1, 2, 4-triazine derivatives for the treatment of viral infections
PH12016501724A1 (en) Isoindolinone compounds as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
PH12016501619A1 (en) Substituted fused heterocycles as gpr119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders
WO2015059463A3 (en) Treatment of beta-catenin related diseases8
IN2012DN02793A (ko)
EA032927B1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
MX366499B (es) Composicion farmaceutica liquida.
MX2015014958A (es) Nuevos derivados de triazolona o sales de la misma y composicion farmaceutica que comprende a la misma.
WO2016140910A3 (en) Compositions and methods of using anti-mullerian hormone for treatment of infertility
IN2014MU00916A (ko)
WO2015111004A3 (en) Improved process for the preparation of chlorophenyl trifluoroethanone
WO2016020408A3 (en) Compounds for preventing ototoxicity
WO2014128728A3 (en) Solid forms of cabazitaxel and processes for preparation thereof
WO2015044434A3 (de) FLUOR-9-METHYL-ß-CARBOLINE
IN2013MU02055A (ko)
WO2014159501A3 (en) Processes for preparing tetrahydroisoquinolines